Kolexia
Hureaux Jose Pneumologie
Hureaux Jose
Pneumologie
Hôpital Larrey Angers
Angers, France
130 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Métastase tumorale Carcinomes Pleurésie Tumeurs du cerveau Carcinome bronchogénique Adénocarcinome

Collaborateurs

Voir plus
Urban Thierry
Urban Thierry
Hôpital Larrey Angers, Angers, France
Molinier Olivier
Molinier Olivier
Centre Hospitalier du Mans, Le Mans, France
Moro-Sibilot Denis
Moro-Sibilot Denis
Hôpital Nord Grenoble, La Tronche, France
Monnet Isabelle
Monnet Isabelle
Centre Hospitalier Intercommunal Créteil, Créteil, France

Industries

Voir plus
B3TSI
42 collaboration(s)
Dernière en 2023
IQVIA
40 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
20 collaboration(s)
Dernière en 2023
Ipsos Mori UK Limited
17 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE): Official Title: A Phase II Multicenter, Open Label, Non-randomized Study of Neoadjuvant and Adjuvant Treatment With IPH5201 and Durvalumab in Patients With Resectable, Early-stage (II to IIIA) Non-Small Cell Lung Cancer (MATISSE)
Essai Clinique (Innate Pharma)   13 mars 2024
ENCO-BRAF: A Phase II Study of the BRAF Inhibitor Encorafenib in Combination With the MEK Inhibitor Binimetinib in Patients With BRAFV600E-mutant Metastatic Non-small Cell Lung Cancer
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   06 mars 2024
PACT-01: Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
Essai Clinique (Institut Curie)   29 janvier 2024
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Essai Clinique (Razor Genomics)   20 décembre 2023
Pulmonary Artery Embolization in the Management of Hemoptysis Related to Lung Tumors.
Journal of personalized medicine   12 novembre 2023
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study.
Lung cancer (Amsterdam, Netherlands)   22 septembre 2023
The place of the relative at the time of the announcement of cancer progression: BABEL - a mixed-methods study.
Palliative & supportive care   26 juin 2023
Capmatinib chez les patients porteurs d’un cancer bronchique non à petites cellules avec une mutation MET exon 14 : résultats de l’étude en vraie vie IFCT-2104 CapmATU
27e Congrès de Pneumologie de Langue Française   01 janvier 2023
1106P Capmatinib for METex14 non-small cell lung cancer patients: Results of the real-world study IFCT-2104 CapmATU
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.
ESMO open   23 décembre 2021